オプションチェーンは、SI-BONEの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、SI-BONEの市場センチメントを評価します。.

SI-BONE (NASDAQ:SIBN) 株価情報, オプションチェーン

SI-BONE

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

SI-BONE Inc

Analyst Drew Ranieri from Morgan Stanley maintained a Buy rating on SI-Bone (SIBN – Research Report) and keeping the price target at $19.00. Drew R...

SI-Bone's Resilience and Growth Potential Amid Challenges: Analyst Maintains Buy Rating

Truist raised the firm's price target on SI-Bone (SIBN) to $18 from $16 and keeps a Buy rating on the shares after its Q3 results. The quarter's po...

SI-Bone price target raised to $18 from $16 at Truist

Morgan Stanley assumed coverage of SI-Bone (SIBN) with an Overweight rating and a price target of $15, down from $19. The firm's lower target facto...

SI-Bone assumed with an Overweight at Morgan Stanley

SI-BONE announces Q4 preliminary worldwide revenue between $48.8 - $49M

Ended the quarter with ~1,390 active physicians in the U.S., representing ~23% growth; Cash and marketable securities of ~$150 million, implying ne...

SI-Bone sees Q4 revenue $48.8M-$49M, consensus $46.89M

Needham analyst David Saxon maintained a Buy rating on SI-Bone (SIBN – Research Report) today and set a price target of $19.00. David Saxon has giv...

SI-Bone's Strong Performance and Growth Prospects Earn 'Buy' Rating from David Saxon

Truist Financial analyst Richard Newitter maintained a Buy rating on SI-Bone (SIBN – Research Report) today. The company's shares closed yesterday ...

Truist Financial Keeps Their Buy Rating on SI-Bone (SIBN)

Next Century Growth Investors Q4 2024 Commentary

Needham raised the firm's price target on SI-Bone (SIBN) to $20 from $19 and keeps a Buy rating on the shares as part of a broader research note on...

SI-Bone price target raised to $20 from $19 at Needham

Top SA Quant-rated medical devices stocks as technicals look strong

ADBE

ALHC

AMZN

APPF

ATRO

AVAV

AVPT

AXGN

AXON

BFLY

BWIN

CAVA

CBLL

CDNA

CERS

CLPT

CNMD

DCTH

DXCM

ECOR

EMBC

ENOV

GDYN

GKOS

GWRE

INGN

INOD

KIDS

KRMD

KRUS

LNSR

LNTH

MNDY

MPTI

MPWR

MYRG

NPCE

NSSC

NVDA

ODFL

PCTY

PEGA

PNFP

PRCT

PYCR

RMTI

RXST

SAIA

SARO

SIBN

SMTI

SPSC

TMDX

TNDM

TOST

TSLA

USAP

VERX

VRRM

VRTX

WDAY

WEAV

WING

XMTR

Earnings

Press Releases

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

Health Care

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

News

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

General

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024

AngioDynamics

Artivion

Alphatec Holdings

AtriCure

Axogen

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

ClearPoint Neuro

Conmed

CVRx

Delcath Systems

Paragon 28

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

NeuroPace

Orthofix Medical

Omnicell

Pulse Biosciences

Senseonics Holdings

Semler Scientific

Surmodics

Tactile Systems Technology, Inc. - Common Stock

Tactile Systems Tech

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Varex Imaging

ZimVie

Needham

Truist Securities

Morgan Stanley

JMP Securities

Piper Sandler

Comments

SI-BONE

SI-BONE (SIBN) オプション

SI-BONE (NASDAQ:SIBN) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル